Holen Sie sich die Stockscreener-App
339.26
0.54%
-1.405
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Elevance Steps In As UnitedHealth Delays — Will It Set The Tone For Insurers?UnitedHealth Group (NYSE:UNH) - Benzinga
Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits? - TradingView
UBS Maintains Buy Rating, Lowers Price Target for Elevance Health (ELV) | ELV Stock News - GuruFocus
UBS Adjusts Price Target on Elevance Health to $484 From $555, Maintains Buy Rating - MarketScreener
Elevance Health (ELV) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Elevance Health a Top Socially Responsible Dividend Stock With 2.0% Yield (ELV) - Nasdaq
Elevance Health (ELV) Target Price Lowered by UBS Analyst | ELV Stock News - GuruFocus
Elevance Health, Inc. (NYSE:ELV) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
FINAL ELV DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Urgently Encourages Investors to Contact the Firm - GlobeNewswire
Elevance Health stock hits 52-week low at 339.38 USD - Investing.com
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV - TradingView
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - GlobeNewswire
Wells Fargo Maintains a Buy on Elevance Health (ELV), Sets a $478 PT - MSN
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Bernstein Maintains a Buy on Elevance Health (ELV), Sets a $585 PT - Insider Monkey
Guggenheim Adjusts Price Target on Elevance Health to $447 From $518, Maintains Buy Rating - MarketScreener
Earnings Preview: Elevance Health (ELV) Q2 Earnings Expected to Decline - Yahoo Finance
Elevance Health (ELV) Price Target Reduced by Guggenheim | ELV S - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesELV - FinancialContent
ELV COURT NOTICE: Elevance Health, Inc. Investors may have - GlobeNewswire
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Elevance Health (ELV): Barclays Lowers Price Target Amid Maintai - GuruFocus
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025 - TradingView
Deadline Soon: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, and Elevance, and Encourages Investors to Contact the Firm - Morningstar
Elevance Health, Inc. Investors: Please contact the Portnoy - GlobeNewswire
Wells Fargo Maintained a Buy Rating on Elevance Health (ELV), Kept the PT Unchanged - MSN
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Longview News-Journal
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - Morningstar
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy - Yahoo Finance
Elevance Health, Inc.(NYSE: ELV) dropped from Russell 3000 Growth Index - MarketScreener
UBS Reaffirms Buy on Elevance Despite Adjusted 2025 Earnings Outlook - MSN
Elevance Health's Legal Battle: A Test of Shareholder Rights and Market Integrity - AInvest
What to Expect From Elevance Health's Q2 2025 Earnings Report - Yahoo Finance
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
Elevance Health (NYSE:ELV) shareholders have earned a 9.3% CAGR over the last five years - Yahoo Finance
Insiders At Elevance Health Sold US$6.9m In Stock, Alluding To Potential Weakness - simplywall.st
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - FinancialContent
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - StreetInsider
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who - GlobeNewswire
Is Weakness In Elevance Health, Inc. (NYSE:ELV) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ELV SHAREHOLDER REPORT: Elevance Health, Inc. was Sued for - GlobeNewswire
INVESTOR ALERT: Berger Montague Advises Elevance Health (ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025 - TradingView
ELV Lead Plaintiff Deadline ApproachingRobbins LLP Reminds Investors to Get Information About Leading the Class Action Against Elevance Health, Inc. - The Malaysian Reserve
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
Truist Lowers Elevance Health (ELV) to $500, Keeps Buy Rating - MSN
ELV SHAREHOLDERS: Elevance Health, Inc. Investors are - GlobeNewswire
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):